Drug Executive Collapses During Oval Office Event
A press conference in the Oval Office was interrupted when a drug executive fainted while President Donald Trump announced a deal with pharmaceutical companies to reduce obesity drug prices.
Incident Details
During the event on Thursday, representatives from drugmakers Eli Lilly and Novo Nordisk discussed expanding coverage and lowering prices for their obesity treatments, Zepbound and Wegovy. David Ricks, CEO of Eli Lilly, noticed the executive’s distress and asked,
“Are you OK? Gordon, are you OK?”
Response and Identification
The man who collapsed was identified by Getty Images’ photographer as Gordon Findlay, the global brand director for Novo Nordisk. Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, immediately assisted Findlay as he fell to his knees and collapsed.
Press Reaction
Following the incident, the press were quickly escorted out of the Oval Office. Health and Human Services Secretary was also present during the event.
Summary
The sudden collapse of a drug executive highlighted the tense atmosphere as President Trump and pharmaceutical leaders negotiated drug price reductions.
Author’s summary: A pivotal Oval Office press event on drug price cuts was abruptly interrupted when a Novo Nordisk executive collapsed, prompting swift aid from Dr. Mehmet Oz.
More News
- Cristiano Ronaldo Breaks Silence On Not Attending Diogo Jota's Funeral: 'After My Father Died...'
- Carlton vs West Coast AFLW LIVE: ‘He would be loving it’: Mia Austin pays tribute to cousin as Blues win elimination final
- Musk plans potential Tesla-Intel partnership
- Eagles ROCKED! First-ever finals match one to forget
- Maxime Raynaud Outlines Kings Defensive Shortcomings, Hartenstein's Career-night In Loss To Thunder
- You need to watch these 10 Aussie movies
- Hartenstein has 33 points and 19 rebounds to help the Thunder rout the Kings